| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-975 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57419 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2000-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2003-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30dd3a428d13c3b8d6a4ab52e05df47c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a48762c55d3e34c28a8137d4a317c527
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1090c7a445738fd06f50fe3f396da8f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3013d450af0552817bf976c92746bd8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_909f001b7d0f0b1822b0fa2de0263d1d |
| publicationDate |
2003-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6531319-B1 |
| titleOfInvention |
Method of detecting colon cancer |
| abstract |
An immunological assay and kit for colon cancer screening is disclosed. Fecal glycoproteins are extracted from individual samples such that immunogenicity is maintained. The purified fecal glycoproteins are reacted with antibodies to Colon and Ovarian Tumor Antigen (COTA). The mucin antigen COTA is specifically present in colorectal cancer tissue and not in normal colons. The amount of COTA in the fecal sample is determined and used to indicate the presence of colon cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009263905-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2110668-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012150453-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9448145-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10023214-B2 |
| priorityDate |
2000-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |